CID 71462571

Chembl2178575

Structural Information

Molecular Formula
C21H19ClN4O5S2
SMILES
COC1=CC=CC2=C1C(=NN2CC3=CC(=CC=C3)NC(=O)CO)NS(=O)(=O)C4=CC=C(S4)Cl
InChI
InChI=1S/C21H19ClN4O5S2/c1-31-16-7-3-6-15-20(16)21(25-33(29,30)19-9-8-17(22)32-19)24-26(15)11-13-4-2-5-14(10-13)23-18(28)12-27/h2-10,27H,11-12H2,1H3,(H,23,28)(H,24,25)
InChIKey
JVBQEIRQUCWMTR-UHFFFAOYSA-N
Compound name
N-[3-[[3-[(5-chlorothiophen-2-yl)sulfonylamino]-4-methoxyindazol-1-yl]methyl]phenyl]-2-hydroxyacetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

48
Patents

506.04855 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 507.05583 214.3
[M+Na]+ 529.03777 223.8
[M-H]- 505.04127 222.9
[M+NH4]+ 524.08237 223.7
[M+K]+ 545.01171 217.2
[M+H-H2O]+ 489.04581 208.6
[M+HCOO]- 551.04675 222.8
[M+CH3COO]- 565.06240 234.9
[M+Na-2H]- 527.02322 215.6
[M]+ 506.04800 224.4
[M]- 506.04910 224.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe